19602874

Source:http://linkedlifedata.com/resource/pubmed/id/19602874

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023449, umls-concept:C0023473, umls-concept:C0025344, umls-concept:C0030705, umls-concept:C1268567, umls-concept:C1561960, umls-concept:C1948053, umls-concept:C2347804, umls-concept:C2757011
pubmed:issue	1
pubmed:dateCreated	2009-10-21
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0141053
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/4-methyl-N-(3-(4-methylimidazol-1-yl..., http://linkedlifedata.com/resource/pubmed/chemical/Aniline Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Nitriles, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Quinolines, http://linkedlifedata.com/resource/pubmed/chemical/Thiazoles, http://linkedlifedata.com/resource/pubmed/chemical/bosutinib, http://linkedlifedata.com/resource/pubmed/chemical/dasatinib, http://linkedlifedata.com/resource/pubmed/chemical/imatinib
pubmed:status	MEDLINE
pubmed:issn	1421-9662
pubmed:author	pubmed-author:AsenovaSvetlanaS, pubmed-author:AyukFrancisF, pubmed-author:BacherUlrikeU, pubmed-author:BrummendorfTim HTH, pubmed-author:KlyuchnikovEvgenyE, pubmed-author:KrögerNicolausN, pubmed-author:OcheniSundayS, pubmed-author:OsanmazOkayO, pubmed-author:SchafhausenPhilippeP, pubmed-author:ZabelinaTatjanaT, pubmed-author:ZanderAxel RAR
pubmed:issnType	Electronic
pubmed:volume	122
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	6-10
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:19602874-Aged, pubmed-meshheading:19602874-Aniline Compounds, pubmed-meshheading:19602874-Female, pubmed-meshheading:19602874-Humans, pubmed-meshheading:19602874-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:19602874-Male, pubmed-meshheading:19602874-Middle Aged, pubmed-meshheading:19602874-Nitriles, pubmed-meshheading:19602874-Piperazines, pubmed-meshheading:19602874-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:19602874-Protein Kinase Inhibitors, pubmed-meshheading:19602874-Protein-Tyrosine Kinases, pubmed-meshheading:19602874-Pyrimidines, pubmed-meshheading:19602874-Quinolines, pubmed-meshheading:19602874-Stem Cell Transplantation, pubmed-meshheading:19602874-Thiazoles
pubmed:year	2009
pubmed:articleTitle	Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.
pubmed:affiliation	Interdisciplinary Clinic for Stem Cell Transplantation, University Cancer Center Hamburg, Hamburg, Germany.
pubmed:publicationType	Journal Article